Prism Medico And Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 10-07-2024
- Paid Up Capital ₹ 6.06 Cr
as on 10-07-2024
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Prism Medico And Pharmacy
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 512217.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 6.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Prism Medico And Pharmacy Limited India are Bharat Singh as CFO and Sameer Gupta as Company Secretary. Vishwambhar Gupta, Dinesh Kumar, Davender Singh, and Two other members serve as directors at the Company.
- CIN/LLPIN
L24100HP2002PLC009299
- Company No.
047444
- Stock Symbol
BSE : 512217
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Prism Medico And Pharmacy?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharat Singh | CFO | 16-May-2023 | Current |
| Sameer Gupta | Company Secretary | 08-Jun-2020 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishwambhar Gupta  | Director | 16-May-2023 | Current |
| Dinesh Kumar | Director | 14-Aug-2023 | Current |
| Davender Singh | Director | 30-Dec-2021 | Current |
| Pardeep Kumar | Director | 30-Dec-2021 | Current |
| Sakshi Laller | Whole-Time Director | 16-May-2023 | Current |
Financial Performance and Corporate Structure Insights of Prism Medico And Pharmacy.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Prism Medico And Pharmacy?
Unlock access to Prism Medico And Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Symbiosis Pharmaceuticals Private LimitedActive 21 years 8 monthsVishwambhar Gupta is a mutual person
_PRIVATE_LIMITED.webp)
Micro-Organics Pharmaceuticals (India) Private LimitedActive 18 years 8 monthsDinesh Kumar is a mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prism Medico And Pharmacy?
Unlock and access historical data on people associated with Prism Medico And Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prism Medico And Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prism Medico And Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
